Literature DB >> 27063215

MicroRNA-124 negatively regulates LPS-induced TNF-α production in mouse macrophages by decreasing protein stability.

Yang Sun1, Zhen Qin1, Qi Li1, Jing-Jing Wan1, Ming-He Cheng1, Peng-Yuan Wang1, Ding-Feng Su1, Jian-Guang Yu1, Xia Liu1.   

Abstract

AIM: MicroRNAs play pivotal roles in regulation of both innate and adaptive immune responses. In the present study, we investigated the effects of microRNA-124 (miR-124) on production of the pro-inflammatory cytokine TNF-α in lipopolysaccharide (LPS)-treated mouse macrophages.
METHODS: Mouse macrophage cell line RAW264.7 was stimulated with LPS (100 ng/mL). The levels of miR-124 and TNF-α mRNA were evaluated using q-PCR. ELISA and Western blotting were used to detect TNF-α protein level in cell supernatants and cells, respectively. 3'-UTR luciferase reporter assays were used to analyze the targets of miR-124. For in vivo experiments, mice were injected with LPS (30 mg/kg, ip).
RESULTS: LPS stimulation significantly increased the mRNA level of miR-124 in RAW264.7 macrophages in vitro and mice in vivo. In RAW264.7 macrophages, knockdown of miR-124 with miR-124 inhibitor dose-dependently increased LPS-stimulated production of TNF-α protein and prolonged the half-life of TNF-α protein, but did not change TNF-α mRNA levels, whereas overexpression of miR-124 with miR-124 mimic produced the opposite effects. Furthermore, miR-124 was found to directly target two components of deubiquitinating enzymes: ubiquitin-specific proteases (USP) 2 and 14. Knockdown of USP2 or USP14 accelerated protein degradation of TNF-α, and abolished the effect of miR-124 on TNF-α protein stability.
CONCLUSION: miR-124, targeting USP2 and USP14, negatively regulates LPS-induced TNF-α production in mouse macrophages, suggesting miR-124 as a new therapeutic target in inflammation-related diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27063215      PMCID: PMC4933752          DOI: 10.1038/aps.2016.16

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  36 in total

Review 1.  Macrophage biology and pathobiology in the evolution of immune responses: a functional analysis.

Authors:  N Stoy
Journal:  Pathobiology       Date:  2001       Impact factor: 4.342

Review 2.  The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC.

Authors:  Marc R Fabian; Nahum Sonenberg
Journal:  Nat Struct Mol Biol       Date:  2012-06-05       Impact factor: 15.369

Review 3.  Biological functions of microRNAs: a review.

Authors:  Yong Huang; Xing Jia Shen; Quan Zou; Sheng Peng Wang; Shun Ming Tang; Guo Zheng Zhang
Journal:  J Physiol Biochem       Date:  2010-10-28       Impact factor: 4.158

4.  MicroRNA-124 protects against focal cerebral ischemia via mechanisms involving Usp14-dependent REST degradation.

Authors:  Thorsten R Doeppner; Maria Doehring; Eva Bretschneider; Anil Zechariah; Britta Kaltwasser; Barbara Müller; Jan C Koch; Mathias Bähr; Dirk M Hermann; Uwe Michel
Journal:  Acta Neuropathol       Date:  2013-06-11       Impact factor: 17.088

5.  MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2.

Authors:  Jin Hou; Pin Wang; Li Lin; Xingguang Liu; Feng Ma; Huazhang An; Zhugang Wang; Xuetao Cao
Journal:  J Immunol       Date:  2009-07-13       Impact factor: 5.422

6.  The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors.

Authors:  Jae-Min Yuk; Dong-Min Shin; Hye-Mi Lee; Jwa-Jin Kim; Sun-Woong Kim; Hyo Sun Jin; Chul-Su Yang; Kyeong Ah Park; Dipanjan Chanda; Don-Kyu Kim; Song Mei Huang; Sang Ki Lee; Chul-Ho Lee; Jin-Man Kim; Chang-Hwa Song; Soo Young Lee; Gang Min Hur; David D Moore; Hueng-Sik Choi; Eun-Kyeong Jo
Journal:  Nat Immunol       Date:  2011-07-03       Impact factor: 25.606

7.  The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.

Authors:  Jayoung Kim; Wun-Jae Kim; Zhiqian Liu; Massimo Loda; Michael R Freeman
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

8.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

9.  MicroRNA-92a negatively regulates Toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase.

Authors:  Lihua Lai; Yinjing Song; Yang Liu; Qingyun Chen; Quan Han; Weilin Chen; Ting Pan; Yuanyuan Zhang; Xuetao Cao; Qingqing Wang
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

10.  The repertoires of ubiquitinating and deubiquitinating enzymes in eukaryotic genomes.

Authors:  Andrew Paul Hutchins; Shaq Liu; Diego Diez; Diego Miranda-Saavedra
Journal:  Mol Biol Evol       Date:  2013-02-07       Impact factor: 16.240

View more
  21 in total

1.  MicroRNAs associated with inflammation in shoulder tendinopathy and glenohumeral arthritis.

Authors:  Finosh G Thankam; Chandra S Boosani; Matthew F Dilisio; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2017-06-20       Impact factor: 3.396

2.  miR-135a deficiency inhibits the AR42J cells damage in cerulein-induced acute pancreatitis through targeting FAM129A.

Authors:  Kai-Kai Zhang; Shan-Shan Yu; Gui-Yun Li; Lian He; Xian-Quan Liang
Journal:  Pflugers Arch       Date:  2019-11-15       Impact factor: 3.657

3.  Safety and efficacy of the miR-124 upregulator ABX464 (obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and/or anti-TNFα therapy: a placebo-controlled phase II study.

Authors:  Claire Daien; Marek Krogulec; Paul Gineste; Jean-Marc Steens; Laurence Desroys du Roure; Sophie Biguenet; Didier Scherrer; Julien Santo; Hartmut Ehrlich; Patrick Durez
Journal:  Ann Rheum Dis       Date:  2022-05-31       Impact factor: 27.973

Review 4.  Meddling with Fate: The Proteasomal Deubiquitinating Enzymes.

Authors:  Stefanie A H de Poot; Geng Tian; Daniel Finley
Journal:  J Mol Biol       Date:  2017-10-05       Impact factor: 5.469

Review 5.  The Proteasome and Its Network: Engineering for Adaptability.

Authors:  Daniel Finley; Miguel A Prado
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-01-02       Impact factor: 10.005

Review 6.  Role of Epigenetics in the Regulation of Immune Functions of the Skin.

Authors:  Yu Sawada; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2020-11-27       Impact factor: 8.551

7.  Downregulated expression of microRNA-124 in pediatric intestinal failure patients modulates macrophages activation by inhibiting STAT3 and AChE.

Authors:  Yong-Tao Xiao; Jun Wang; Wei Lu; Yi Cao; Wei Cai
Journal:  Cell Death Dis       Date:  2016-12-15       Impact factor: 8.469

8.  D-4F increases microRNA-124a and reduces neuroinflammation in diabetic stroke rats.

Authors:  Ruizhuo Ning; Poornima Venkat; Michael Chopp; Alex Zacharek; Tao Yan; Xu Cui; Don Seyfried; Jieli Chen
Journal:  Oncotarget       Date:  2017-09-08

Review 9.  miRNA-124 in Immune System and Immune Disorders.

Authors:  Zhen Qin; Peng-Yuan Wang; Ding-Feng Su; Xia Liu
Journal:  Front Immunol       Date:  2016-10-04       Impact factor: 7.561

10.  ICAM-1 regulates macrophage polarization by suppressing MCP-1 expression via miR-124 upregulation.

Authors:  Wei Gu; Lun Yao; Lexing Li; Jianping Zhang; Aaron T Place; Richard D Minshall; Guoquan Liu
Journal:  Oncotarget       Date:  2017-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.